mycophenolic acid (MPA) antibody and antigen (hapten, BSA/OVA conjugated)
Diagnostic anti-mycophenolic acid (MPA) antibodies (anti-mycophenolic acid, anti-MPA) and diagnostic hapten-carrier conjugates BSA-mycophenolic acid (MPA), OVA-mycophenolic acid (MPA), KLH-mycophenolic acid (MPA) antigens for Inflammation/autoimmune/inflammatory disease MPA detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Inflammation/autoimmune/inflammatory disease diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-SMT-MPA-Ag01 | BSA-mycophenolic acid (MPA) | $756.00 |
GMP-SMT-MPA-Ag02 | OVA-mycophenolic acid (MPA) | $756.00 |
GMP-SMT-MPA-Ab01 | Anti-human mycophenolic acid (MPA) mouse monoclonal antibody (mAb) | $1953.00 |
GMP-SMT-MPA-Ab02 | Anti-human mycophenolic acid (MPA) human monoclonal antibody (mAb) | $1953.00 |
Size: 1mg | 10mg | 100mg
Product Description
BSA-mycophenolic acid (MPA)
Cat No. | GMP-SMT-MPA-Ag01 |
Product Name | BSA-mycophenolic acid (MPA) |
Target | mycophenolic acid (MPA) |
Expression platform | Synthetic |
Bioactivity validation | mycophenolic acid (MPA) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in MPA level test of Inflammation/autoimmune/inflammatory disease (autoimmune disease) and related syndrome evaluation |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-mycophenolic acid (MPA) / OVA-mycophenolic acid (MPA) is Synthetic. |
Purity | High (TBD) |
Application | Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
OVA-mycophenolic acid (MPA)
Cat No. | GMP-SMT-MPA-Ag02 |
Product Name | OVA-mycophenolic acid (MPA) |
Target | mycophenolic acid (MPA) |
Expression platform | Synthetic |
Bioactivity validation | mycophenolic acid (MPA) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in MPA level test of Inflammation/autoimmune/inflammatory disease (autoimmune disease) and related syndrome evaluation/td> |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-mycophenolic acid (MPA) / OVA-mycophenolic acid (MPA) is Synthetic. |
Purity | High (TBD) |
Application | Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-human mycophenolic acid (MPA) mouse monoclonal antibody (mAb)
Cat No. | GMP-SMT-MPA-Ab01 |
Product Name | Anti-human mycophenolic acid (MPA) mouse monoclonal antibody (mAb) |
Target | mycophenolic acid (MPA) |
Expression platform | hybridoma |
Isotypes | Mouse IgG |
Bioactivity validation | mycophenolic acid (MPA) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other mycophenolic acid (MPA) antibodies in MPA level test of Inflammation/autoimmune/inflammatory disease (autoimmune disease) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human mycophenolic acid (MPA) mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by hybridoma technology. |
Purity | High (TBD) |
Application | Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-human mycophenolic acid (MPA) human monoclonal antibody (mAb)
Cat No. | GMP-SMT-MPA-Ab02 |
Product Name | Anti-human mycophenolic acid (MPA) human monoclonal antibody (mAb) |
Target | mycophenolic acid (MPA) |
Expression platform | hybridoma |
Isotypes | Human IgG1 |
Bioactivity validation | mycophenolic acid (MPA) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other mycophenolic acid (MPA) antibodies in MPA level test of Inflammation/autoimmune/inflammatory disease (autoimmune disease) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human mycophenolic acid (MPA) mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS, PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Mycophenolic acid (MPA) is an immunosuppressant medication used to prevent rejection following organ transplantation and to treat autoimmune conditions such as Crohn's disease and lupus. Specifically it is used following kidney, heart, and liver transplantation. It can be given by mouth or by injection into a vein. It comes as mycophenolate sodium and mycophenolate mofetil.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.